Cargando…

Efficacy of Double Dose Recombinant Hepatitis B Vaccination in Chronic Hepatitis C Patients, Compared to Standard Dose Vaccination

BACKGROUND: Hepatitis B virus (HBV) vaccination is a well-known, safe and effective way for protection against HBV infection; however, non-responders remain susceptible to infection with HBV. This is so important in patients with any kind of chronic liver disease, especially chronic hepatitis C viru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minakari, Mohammad, Tahmasebi, Afshin, Motlagh, Mahyar Hosseini, Ataei, Behrooz, Yaran, Majid, Kalantari, Hamid, Tavakkoli, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950735/ https://www.ncbi.nlm.nih.gov/pubmed/24627739

Ejemplares similares

Prevalence of interleukin-28B single nucleotide polymorphism genotypes in patients with hepatitis C infection in Isfahan, Iran
por: Minakari, Mohammad, et al.
Publicado: (2016)

Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
por: Ataei, Behrooz, et al.
Publicado: (2011)

Statin efficacy in the treatment of hepatitis C genotype I
por: Shavakhi, Ahmad, et al.
Publicado: (2014)

Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran
por: Kalantari, Hamid, et al.
Publicado: (2016)

Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study
por: Vakili, Bahareh, et al.
Publicado: (2014)

Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
por: Javadi, Abbasali, et al.
Publicado: (2014)

Validation of Hepascore as a Predictor of Liver Fibrosis in Patients with Chronic Hepatitis C Infection
por: Kalantari, Hamid, et al.
Publicado: (2011)

Correlation between Vitamin D3 level and extrahepatic manifestation in chronic hepatitis type-C virus patients
por: Kalantari, Hamid, et al.
Publicado: (2018)

Seroprevalence of Hepatitis A in Patients with Chronic Hepatitis C in Isfahan Province
por: Shoaei, Parisa, et al.
Publicado: (2012)

Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors
por: Kassaian, Nazila, et al.
Publicado: (2011)

Seroprevalence of hepatitis B markers among incarcerated intravenous drug users
por: Nokhodian, Zary, et al.
Publicado: (2014)

Seroprevalence of hepatitis B virus infection and hepatitis B surface antibody status among laboratory health care workers in Isfahan, Iran
por: Shoaei, Parisa, et al.
Publicado: (2015)

Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners
por: Ataie, Mehdi, et al.
Publicado: (2013)

Isolation of Hepatitis C Virus in Norjizac Vials
por: Tayeri, Katayoon, et al.
Publicado: (2010)

Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran
por: Nokhodian, Zary, et al.
Publicado: (2012)

Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran
por: Kalantari, Hamid, et al.
Publicado: (2014)

The assessment of hepatitis B seroprevalence in persons with intravenous drug use history in the Isfahan province: Community-based study
por: Khodadoostan, Mahsa, et al.
Publicado: (2014)

Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study
por: Mostafavi, Nasser, et al.
Publicado: (2016)

Seroprevalence of Hepatitis C Infection among Laboratory Health Care Workers in Isfahan, Iran
por: Shoaei, Parisa, et al.
Publicado: (2012)

Comparison of Immunogenicity and Safety of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: A Randomized, Controlled Trial
por: Chaiklang, Kanokporn, et al.
Publicado: (2013)

286. Hepatitis B Vaccine Compliance: Comparing 2-Dose and 3-Dose Vaccines
por: Bruxvoort, Katia, et al.
Publicado: (2019)

Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors
por: Nokhodian, Zary, et al.
Publicado: (2012)

Seroprevalence of Hepatitis B Infection and Associated Risk Factors among Drug Users in Drop-in Centers of Isfahan, Iran
por: Taleban, Roya, et al.
Publicado: (2018)

Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran
por: Nokhodian, Zary, et al.
Publicado: (2012)

2231. Long-Term Immunogenicity of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: An Extension of a Randomized Controlled Trial
por: Chaiwarith, Romanee, et al.
Publicado: (2018)

Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination
por: Zhao, Yu-Liang, et al.
Publicado: (2019)

Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2012)

Three Doses of Hepatitis B Vaccine or Four Doses in Chronic Renal Failure
por: Khazaeipour, Zahra, et al.
Publicado: (2013)

Is hepatitis B birth dose vaccine needed in Africa?
por: Tamandjou, Cynthia Raissa, et al.
Publicado: (2017)

Safety and Immunogenicity of Standard and Double Doses of Hepatitis B Vaccine in Children after Liver Transplantation: An Open-Label, Randomised Controlled Trial
por: Sintusek, Palittiya, et al.
Publicado: (2022)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial
por: Joukar, Farahnaz, et al.
Publicado: (2016)

Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants
por: Lei, Donna, et al.
Publicado: (2022)

Evaluation of knowledge and practice of hairdressers in men's beauty salons in Isfahan about hepatitis B, hepatitis C, and AIDS in 2010 and 2011
por: Ataei, Behrooz, et al.
Publicado: (2012)

Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China
por: Miao, Ning, et al.
Publicado: (2020)

Diagnostic Value of Pyruvate Kinase Isoenzyme Type M2 in Colon Cancer Proven with Colonoscopy
por: Kalantari, Hamid, et al.
Publicado: (2020)

Hepatitis B At-Birth Dose Vaccine: An Urgent Call for Implementation in Ghana
por: Awuku, Yaw Asante, et al.
Publicado: (2018)

The impact of the timely birth dose vaccine on the global elimination of hepatitis B
por: de Villiers, Margaret J., et al.
Publicado: (2021)

Serological response to one intradermal or intramuscular hepatitis B virus vaccine booster dose in human immunodeficiency virus-infected nonresponders to standard vaccination
por: Ramezani, Amitis, et al.
Publicado: (2014)

Identification of Patients with Hepatitis C Virus Infection in Persons with Background of Intravenous Drug Use: The First Community Announcement-based Study From Iran
por: Nobari, Reza Fadaei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kt7edt588rh4gk545onq2sqrgg